Anthropic PBC’s announcement that its Claude AI model discovered an enzyme system that resembled an earlier breakthrough gene editing technology was met with caution by some experts in the field, who suggested the company oversold its significance.

UniQure NV shares soared after the company announced it will be able to seek US approval for its Huntington’s disease gene therapy before conducting a new study, a dramatic reversal that shows the Trump administration is relaxing its previous hard-line stance on drug reviews.

Tango Therapeutics Inc. jumped as much as 48% after initial results of a study showed a combination of its drug and a Revolution Medicines Inc. medicine shrunk tumors in advanced pancreatic cancer patients.

The US health department’s inspector general is investigating whether a top US Food and Drug Administration official misled the federal government by using a sham divorce to avoid running afoul of conflict-of-interest rules, people familiar with the investigation said.